Statements (60)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:virus
|
| gptkbp:cause |
gptkb:Yellow_fever
|
| gptkbp:community_health |
gptkb:Yes
Vaccine campaigns |
| gptkbp:death |
20% to 50% in severe cases
|
| gptkbp:diagnosis |
Serological tests
PCR tests |
| gptkbp:discovered_by |
gptkb:Max_Theiler
|
| gptkbp:discovery_year |
1900
|
| gptkbp:diseases |
Liver damage
Hemorrhagic fever Common in tropical areas |
| gptkbp:endemic_to |
gptkb:Africa
gptkb:South_America |
| gptkbp:epidemiology |
Seasonal outbreaks
Important for outbreak prevention |
| gptkbp:family |
gptkb:Flaviviridae
|
| gptkbp:genus |
gptkb:Flavivirus
|
| gptkbp:historical_impact |
Significant in American history
Caused major epidemics in the 19th century Influenced urban planning in cities like New Orleans |
| https://www.w3.org/2000/01/rdf-schema#label |
Yellow fever virus
|
| gptkbp:incubation_period |
3 to 6 days
|
| gptkbp:is_vulnerable_to |
Live attenuated vaccine
95% or higher Healthcare workers in endemic areas Laboratory workers handling the virus Military personnel in endemic areas Travelers to endemic regions |
| gptkbp:prevention |
Vaccination
|
| gptkbp:public_awareness |
Critical for vaccination uptake
|
| gptkbp:replaces |
1930s
|
| gptkbp:research |
Ongoing vaccine development
|
| gptkbp:reservoir |
Non-human primates
|
| gptkbp:risk_factor |
gptkb:Teenager
Unvaccinated individuals Travel to endemic areas Immune status |
| gptkbp:scientific_classification |
Category A
|
| gptkbp:symptoms |
gptkb:Fever
gptkb:Nausea Fatigue Vomiting Headache Abdominal pain Bleeding Chills Jaundice Muscle pain Loss of appetite |
| gptkbp:transmission |
gptkb:Aedes_mosquitoes
|
| gptkbp:treatment |
Supportive care
No specific antiviral treatment |
| gptkbp:vaccine_available_since |
1937
|
| gptkbp:vaccine_duration |
10 years or more
|
| gptkbp:vector |
gptkb:Aedes_aegypti
gptkb:Haemagogus_mosquitoes |
| gptkbp:bfsParent |
gptkb:West_Nile_virus
gptkb:Flaviviridae |
| gptkbp:bfsLayer |
5
|